期刊文献+

RP-HPLC法测定人血浆中阿昔洛韦的方法改进 被引量:5

AN IMPROVED RP HPLC METHOD FOR THE DETERMINATION OF ACYCLOVIR IN PLASMA
暂未订购
导出
摘要 目的 :用改良高效液相色谱法测定人血浆中阿昔洛韦浓度。方法 :以甲醇 重蒸馏水 (5∶95 )为流动相 ,检测波长 2 5 0nm ,鸟苷作内标 ,血浆样品采用 2 0 %高氯酸沉淀蛋白后进样。结果 :阿昔洛韦在 0 .0 31~ 2 .0mg·L-1范围内线性关系良好 ,最低检测浓度为 0 .0 1mg·L-1,高、中、低浓度日内RSD分别为 2 .5 % ,1.2 %和 2 .3% ;日间RSD分别为2 .4% ,5 .8%和 2 .7%。结论 :该法操作简便 ,灵敏度高 ,色谱峰分离好。 OBJECTIVE: A simple, sensitive and rapid HPLC method has been developed for the determination of acyclovir in plasma. METHODS: A Waters HPLC instrument with YMC Pack ODS (250 mm×4.6 mm, 5 μm) as column packing was used . The mobile phase was a mixture of methanol and water (5∶95 V/V) with a flow rate of 1.0 ml·min -1 , and the ultraviolet wavelength was set at 250 nm. Guanosine was used as internal standard, 20 % perchloric acid was used to precipitate plasma protein. RESULTS:The calibration curve was linear in the range of 0.031~2.0 mg·L -1 , and the limit of quantification was 0.01 mg·L -1 , RSD was less than 6.0 %.CONCLUSION: This method is simple, rapid and sensitive. It has been used in pharmacokinetics and bioavailability study of acyclovir.
出处 《华西药学杂志》 CAS CSCD 北大核心 2000年第5期379-380,共2页 West China Journal of Pharmaceutical Sciences
关键词 阿昔洛韦 高效液相色谱法 血药浓度 Acyclovir RP HPLC Plasma concentration
  • 相关文献

参考文献5

  • 1贺蕊,陈雨安,王征,祁广建.阿昔洛韦胶囊和片剂在人体的生物利用度比较[J].中国医院药学杂志,1994,14(8):345-347. 被引量:3
  • 2张驰,董善年.反相高效液相色谱法测定人血浆中阿昔洛韦浓度[J].药学学报,1993,28(8):629-632. 被引量:15
  • 3Mascher H,Kikuta C and Metz R,et al.New, high-sensitivity high-performance liquid chromatographic method for the determination of acyclovir in human plasma, using fluorometric detection[].Journal of Chromatography.1992
  • 4Boulieu R,Gallant C,Silberstein N.Determination of acyclovir in human plasma by high-performance liquid chromatography[].Journal of Chromatography.1997
  • 5Swart KJ,Hundt HKL,Groenewald AM.Automated high-performance liquid chromatographic method for the determination of acyclovir in plasma[].Journal of Chromatography A.1994

二级参考文献2

  • 1李端,中国医药工业杂志,1992年,23卷,165页
  • 2管瑞琴,医药工业,1986年,17卷,309页

共引文献14

同被引文献24

  • 1黄建明,段更利,陈钧,郑璐侠,邹建军.阿昔洛韦研制片的人体相对生物利用度研究[J].中国新药与临床杂志,2004,23(12):859-861. 被引量:10
  • 2周梅华,郭幼梅,张称心,张莉,杨香绥,李巧云,韩群,李端.反相高效液相色谱法测定阿昔洛韦胶囊在人体内的药动学[J].中国医院药学杂志,1994,14(10):437-438. 被引量:9
  • 3许小红,李铜铃,郑鹏程,杨岚,黄婷,陈束叶.盐酸伐昔洛韦缓释片生物利用度评价[J].四川大学学报(医学版),2005,36(6):898-899. 被引量:6
  • 4陈束叶,李铜铃,张洁,张婷婷,孙健,杨岚,黄婷.盐酸伐昔洛韦片的人体生物等效性[J].中国临床药学杂志,2007,16(2):94-97. 被引量:3
  • 5蒋学华,陈小瑞,程强,胡继承,孙健.盐酸伐昔洛韦片的药动学与生物利用度[J].中国药学杂志,1997,32(2):100-103. 被引量:20
  • 6BAHRAMI G H, MIRZAEEII S H, KIANI A. Determination of acyclovir in human serum by high-performance liquid chromatography using liquid-liquid extraction and its application in pharmacokinetic studies[J]. J Chromatogr B, 2005, 816(1-2): 327-331.
  • 7PHAM-HUY C, STATHOULOPOULOU F, SANDOUK P, et al.Rapid determination of valaciclovir and acyelovir in human biological fluids by high-performance liquid chromatography using isocratic elution[J]. J Chromatogr B, 1999, 732(1): 47-53.
  • 8PALMA-AGUIRRE J A, ABSALON-REYES J A, NOVOA- HECKEL G, et al. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 rag: two single-dose, open-label, randomized, two-period crossover comparisons in healthy mexican adult subjects[J]. Clin Ther, 2007, 29(6): 1146-1152.
  • 9Jacobson MA.Valaciclovir(BW256U87):the L-Valy ester of acyclovir[J].J Med Virol,1993,41(Suppl):S150-S153.
  • 10国家食品药品监督管理局药品审评中心,四川美康医药软件研究开发有限公司.药物临床信息参考[M].2004年版,成都:四川出版集团四川科学技术出版社,2004:229、230.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部